Benralizumab Maintains Remission in Asthma in Some, Not All ...Middle East

Medscape - News
Benralizumab Maintains Remission in Asthma in Some, Not All
Achieving and maintaining clinical remission for up to 2 years is feasible for nearly one third of patients with severe eosinophilic asthma receiving benralizumab. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Benralizumab Maintains Remission in Asthma in Some, Not All )

Also on site :